HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.
about
HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expressionHuman Epidermal Growth Factor Receptor Expression in Colorectal Cancer and Its Relationship with Clinicopathological Characteristics.HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives.
P2860
HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.
@en
HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.
@nl
type
label
HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.
@en
HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.
@nl
prefLabel
HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.
@en
HER2 and immunotherapy using monoclonal antibodies in colorectal cancer.
@nl
P2860
P356
P1433
P1476
HER2 and immunotherapy using monoclonal antibodies in colorectal cancer
@en
P2093
Ehsan Nazemalhosseini Mojarad
P2860
P304
P356
10.2217/IMT.13.131
P50
P577
2013-12-01T00:00:00Z